Post-operative responses of paranasal Aspergillus granuloma to itraconazole.
Paranasal Aspergillus granuloma is an invasive infection, seen mainly in tropical countries, involving the paranasal sinuses, orbit and brain. Previously surgical excision has been followed by a high relapse rate, 80% in some series, and mortality. This study involved the use of post-operative therapy with oral itraconazole in doses of 200-300 mg daily. Twenty-two patients were treated for a mean period of 19.7 weeks. Of 19 patients for whom follow-up data were available, 12 (62%) were rated as being in complete remission in a mean period of 17.2 months after the end of therapy. Only one patient developed progressive disease during itraconazole therapy. No serious adverse effect was seen. Use of itraconazole shows promise as a means of preventing relapse after surgery in this progressive infection.
Gumaa
S A
SA
Department of Medical Microbiology, Faculty of Medicine, University of Khartoum, Republic of Sudan.
Mahgoub
E S
ES
Hay
R J
RJ
D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006099:Granuloma / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D017964:Itraconazole; D007654:Ketoconazole / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010254:Paranasal Sinus Diseases / Q000188:drug therapy* / Q000601:surgery; D011183:Postoperative Complications / Q000517:prevention & control
D000935:Antifungal Agents; D017964:Itraconazole; D007654:Ketoconazole